Document is current
Any future updates will be listed below
-
Authors
Guillemaud, Martin
Longhena, Alice
Cousyn, Louis
Frazzini, Valerio
Mathon, Bertrand
Navarro, Vincent
Chavez, Mario
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 4 July 2025
First Online: 16 July 2025
Competing interests
: V.N. reports fees from Boards with UCB Pharma, EISAI, Liva Nova, and GW Pharma. The remaining authors have no conflicts of interest.
